E. Ohman J or Asset Management AB Makes New Investment in Aflac Incorporated (NYSE:AFL)

E. Ohman J or Asset Management AB bought a new position in shares of Aflac Incorporated (NYSE:AFL) during the 3rd quarter, according to its most recent disclosure with the SEC. The fund bought 22,500 shares of the financial services provider’s stock, valued at approximately $2,516,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of AFL. Brookstone Capital Management raised its position in shares of Aflac by 10.2% in the 1st quarter. Brookstone Capital Management now owns 19,751 shares of the financial services provider’s stock worth $1,696,000 after acquiring an additional 1,828 shares in the last quarter. Wealthcare Advisory Partners LLC raised its position in shares of Aflac by 8.3% in the 1st quarter. Wealthcare Advisory Partners LLC now owns 9,398 shares of the financial services provider’s stock worth $807,000 after acquiring an additional 719 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Aflac by 6.0% in the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 139,665 shares of the financial services provider’s stock worth $11,992,000 after acquiring an additional 7,850 shares in the last quarter. Register Financial Advisors LLC bought a new position in shares of Aflac in the 1st quarter worth about $63,000. Finally, Vicus Capital bought a new position in shares of Aflac in the 1st quarter worth about $264,000. 67.44% of the stock is owned by institutional investors and hedge funds.

Aflac Price Performance

Aflac stock opened at $109.69 on Friday. The company has a market cap of $62.33 billion, a price-to-earnings ratio of 12.11, a PEG ratio of 2.62 and a beta of 0.95. The business’s 50 day simple moving average is $110.22 and its 200 day simple moving average is $96.59. Aflac Incorporated has a 12 month low of $75.07 and a 12 month high of $115.50. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFL) last posted its earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.23. The firm had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The business’s quarterly revenue was down .7% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.58 earnings per share. Sell-side analysts forecast that Aflac Incorporated will post 6.76 EPS for the current year.

Aflac Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Investors of record on Wednesday, August 21st were paid a $0.50 dividend. The ex-dividend date was Wednesday, August 21st. This represents a $2.00 dividend on an annualized basis and a yield of 1.82%. Aflac’s dividend payout ratio is presently 22.08%.

Insider Buying and Selling at Aflac

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the company’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total transaction of $197,880.00. Following the completion of the sale, the director now directly owns 18,158 shares in the company, valued at $1,796,552.52. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 0.90% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on AFL shares. JPMorgan Chase & Co. boosted their target price on Aflac from $85.00 to $90.00 and gave the company a “neutral” rating in a research report on Thursday, October 3rd. UBS Group boosted their price objective on Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. Wells Fargo & Company boosted their price objective on Aflac from $90.00 to $106.00 and gave the stock an “equal weight” rating in a report on Thursday, October 10th. Morgan Stanley boosted their price objective on Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a report on Monday, August 19th. Finally, Bank of America boosted their price objective on Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a report on Thursday, October 10th. Three research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $97.53.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.